Comparison of urinary neopterin and pseudouridine in patients with malignant proliferative diseases.
The HPLC method for the simultaneous determination of urinary neopterin, pseudouridine, and creatinine allows a rapid evaluation of the activation state of cell-mediated immunity, and the stimulation of whole-body rRNA + tRNA turnover, associated with malignant growth. Urinary neopterin and pseudouridine concentrations in healthy subjects amounted to: 106.6 +/- 34.6 mumol/mol creatinine, and 19.6 +/- 5.2 mmol/mol creatinine (mean +/- SD), respectively. The increase of neopterin excretion in patients with haematological neoplasms ranged from 146% in Hodgkin's disease to 534% in non-Hodgkin's lymphoma, whereas the increase in cancer cases ranged from 95% in adenocarcinoma of the gaster to 741% in hepatocellular carcinoma. The changes in pseudouridine excretion were much less pronounced: 63% in non-Hodgkin's lymphoma and 120% in carcinoma of the urinary bladder. The correlation coefficient between neopterin and pseudouridine was relatively low (r = 0.43), although statistically significant (P < 0.01). In the case of several neoplasms e.g. Hodgkin's disease, polycythaemia vera, and adenocarcinoma of the gaster, neopterin was significantly elevated, whereas pseudouridine remained at a normal concentration. There was a positive relationship between the stage of the disease (primary focus, regional metastases, dissemination) and urinary concentration of pseudouridine in patients with adenocarcinoma of the large intestine. In the same patients the increase of neopterin excretion was noticed both in early and advanced stages, with the highest values in disseminated disease.
Motyl
T
T
Department of Animal Physiology, Veterinary Faculty, Warsaw Agricultural University, Poland.
Traczyk
Z
Z
Holska
W
W
Daniewska-Michalska
D
D
Cieśluk
S
S
Kukulska
W
W
Kałuzny
Z
Z
Podgurniak
M
M
D000704:Analysis of Variance; D001708:Biopterins / Q000031:analogs & derivatives* / Q000652:urine; D002851:Chromatography, High Pressure Liquid; D003404:Creatinine / Q000652:urine*; D006801:Humans; D007938:Leukemia / Q000652:urine*; D008223:Lymphoma / Q000652:urine*; D009369:Neoplasms / Q000652:urine*; D019798:Neopterin; D011560:Pseudouridine / Q000652:urine*; D012343:RNA, Transfer / Q000378:metabolism
D011560:Pseudouridine; D001708:Biopterins; D019798:Neopterin; D012343:RNA, Transfer; D003404:Creatinine